Intradigm |
|
||
| Develops a nanoparticle-based siRNA targeting the VEGF (Vascular Endothelial Growth Factor) pathwayas part of its RNA interference (RNAi) therapeutics for the treatment of human diseases. | |||
| Address: | 3350 W Bayshore Rd, Suite 100 | ||
| City: | Palo Alto | ||
| State/Province: | California | ||
| Postcode: | 94303 | ||
| Country: | USA | ||
